Esomeprazole Combix 40 mg gastro-resistant tablets EFG

Spain
Brand name Esomeprazole Combix 40 mg gastro-resistant tablets EFG
Form tablets, enteric-coated
Active substance / Dosage
Prescription type Prescription Only Medicine
Registration number 85920
Esomeprazole Combix 40 mg gastro-resistant tablets EFG tablets, enteric-coated

Package leaflet: Information for the user

Introduction

Package leaflet: information for the patient

Esomeprazol Combix 40 mg gastro-resistant tablets EFG

Read the entire leaflet carefully before you start taking this medicine, because it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only, and you must not give it to other people, even if they have the same symptoms as you, because it could harm them.
  • If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. See section 4.

Contents of the leaflet

  1. What Esomeprazol Combix is and what it is used for
  2. What you need to know before taking Esomeprazol Combix
  3. How to take Esomeprazol Combix
  4. Possible side effects
  5. How to store Esomeprazol Combix
  6. Contents of the pack and other information

1. What Esomeprazol Combix is and what it is used for

Esomeprazol Combix contains a medicine called esomeprazole, which belongs to a group of medicines known as "proton pump inhibitors". These work by reducing the amount of acid produced by the stomach.

Esomeprazole is used to treat the following conditions:

Adults

  • Gastroesophageal reflux disease (GERD). This occurs when stomach acid flows back up into the esophagus (the tube connecting the throat to the stomach), causing pain, inflammation, and heartburn.
  • Excessive stomach acid caused by a tumor in the pancreas (Zollinger-Ellison syndrome).
  • Continuation treatment to prevent re-bleeding from peptic ulcer after initial treatment with intravenous esomeprazole.

Adolescents aged 12 years and older

  • Gastroesophageal reflux disease (GERD). This occurs when stomach acid flows back up into the esophagus (the tube connecting the throat to the stomach), causing pain, inflammation, and heartburn.

2. What you need to know before starting to take Esomeprazol Combix

Do not take Esomeprazol Combix

  • if you are allergic to esomeprazole or to any of the other ingredients of this medicine (listed in section 6).
  • if you are allergic to other medicines in the group of proton pump inhibitors (e.g. pantoprazole, lansoprazole, rabeprazole, omeprazole).
  • if you are taking a medicine containing nelfinavir (used in the treatment of HIV infection).
  • if you have ever developed a severe skin rash, peeling skin, blistering, or mouth ulcers after taking esomeprazole or other related medicines.

If any of these apply to you, do not take esomeprazole. If you are unsure, consult your doctor or pharmacist before taking esomeprazole.

Warnings and precautions

Talk to your doctor or pharmacist before starting to take esomeprazole:

  • if you have severe liver problems.
  • if you have severe kidney problems.
  • if you have ever had a skin reaction after treatment with a medicine similar to esomeprazole used to reduce stomach acid.
  • if you are scheduled to have a specific blood test (chromogranin A).

Esomeprazole may mask symptoms of other diseases. Therefore, if you experience any of the following events before or while taking esomeprazole, contact your doctor immediately:

  • You lose weight significantly without reason and have difficulty swallowing.
  • You have stomach pain or indigestion.
  • You start vomiting food or blood.
  • Your stools appear black (streaked with blood).

If you have been prescribed esomeprazole only when you notice symptoms, you should contact your doctor if your symptoms persist or change.

Taking a proton pump inhibitor such as esomeprazole, especially for a period longer than one year, may slightly increase the risk of fractures of the hip, wrist, or spine.

Inform your doctor if you have osteoporosis or if you are taking corticosteroids (which may increase the risk of osteoporosis).

If you develop a skin rash, especially in areas of skin exposed to sunlight, consult your doctor as soon as possible, as it may be necessary to discontinue treatment with esomeprazole. Remember to mention any other symptoms you may notice, such as joint pain.

Serious skin reactions including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported in association with esomeprazole treatment. Stop taking esomeprazole and seek immediate medical attention if you notice any symptoms related to these serious skin reactions described in section 4.

Children under 12 years of age

Dosage information for children aged 1 to 11 years is provided in the product information for esomeprazole in sachets (consult your doctor or pharmacist if you need additional information).

Other medicines and Esomeprazol Combix

Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines. This includes medicines obtained without a prescription. This is because esomeprazole can affect how some medicines work, and some medicines can influence the effect of esomeprazole.

Do not take esomeprazole if you are taking a medicine containing nelfinavir (used to treat HIV infection).

Inform your doctor if you are taking any of the following medicines:

  • Atazanavir (used to treat HIV infection).
  • Clopidogrel (used to prevent blood clots).
  • Ketoconazole, itraconazole, or voriconazole (for fungal infections).
  • Erlotinib (used in cancer treatment).
  • Citalopram, imipramine, clomipramine (for treatment of depression).
  • Diazepam (used for anxiety, as a muscle relaxant, or for epilepsy).
  • Phenytoin (for epilepsy). If you are taking phenytoin, your doctor will need to monitor you when starting or stopping Esomeprazol Combix.
  • Medicines used to thin the blood such as warfarin. Your doctor may need to monitor you when starting or stopping Esomeprazol Combix.
  • Cilostazol (used to treat intermittent claudication – leg pain when walking caused by insufficient blood flow).
  • Cisapride (used for indigestion and heartburn).
  • Digoxin (used for heart problems).
  • Methotrexate (a chemotherapy medicine used at high doses in cancer treatment) – if you are taking high doses of methotrexate, your doctor may temporarily interrupt your treatment with Esomeprazol Combix.
  • Tacrolimus (organ transplant).
  • Rifampicin (used to treat tuberculosis).
  • St. John’s wort (Hypericum perforatum) (used to treat depression).

If your doctor has prescribed the antibiotics amoxicillin and clarithromycin in addition to esomeprazole to treat ulcers caused by Helicobacter pylori, it is very important that you inform your doctor if you are taking any other medicines.

Taking Esomeprazol Combix with food and drink

You may take the tablets with food or on an empty stomach.

Pregnancy, breastfeeding, and fertility

If you are pregnant, breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine. Your doctor will decide whether you can take esomeprazole during this time.

It is unknown whether esomeprazole passes into breast milk. Therefore, esomeprazole should not be taken during breastfeeding.

Driving and using machines

Esomeprazole is unlikely to affect your ability to drive or operate machinery. However, adverse effects such as dizziness or blurred vision may occur infrequently or rarely (see section 4). You should not drive or operate machinery if you experience any of these effects.

Esomeprazol Combix contains sucrose.

Esomeprazole contains sugar spheres that contain sucrose, a type of sugar. If your doctor has diagnosed you with an intolerance to certain sugars, consult him before taking this medicine.

3. How to take Esomeprazol Combix

Follow exactly the instructions for administering this medicine as given by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.

  • If you take this medicine for a long period of time, your doctor will need to monitor you (especially if you take it for more than one year).
  • If your doctor has instructed you to take this medicine only when you experience symptoms, inform your doctor if your symptoms change.

How much to take

  • Your doctor will have told you how many tablets to take and when to take them. This will depend on your condition, age, and liver function.
  • The recommended doses are indicated below:

Use in adults aged 18 years and older

For the treatment of heartburn caused by gastroesophageal reflux disease (GERD):

  • If your doctor has determined that your esophagus is mildly affected, the recommended dose is one 40 mg esomeprazole gastro-resistant tablet once daily for 4 weeks. Your doctor may instruct you to continue the same dose for another 4 weeks if your esophagus has not yet healed.
  • If you have severe liver problems, your doctor may prescribe a lower dose.

For the treatment of excessive stomach acid caused by a pancreatic tumor (Zollinger-Ellison syndrome):

  • The recommended dose is one 40 mg esomeprazole gastro-resistant tablet twice daily.
  • Your doctor will adjust the dose according to your needs and will also decide how long you should take this medicine. The maximum dose is 80 mg twice daily.

Continuation treatment for prevention of rebleeding from peptic ulcer induced with intravenous esomeprazole:

  • The recommended dose is one 40 mg esomeprazole gastro-resistant tablet once daily for 4 weeks.

Use in adolescents aged 12 years and older

For the treatment of heartburn caused by gastroesophageal reflux disease (GERD):

  • If your doctor has determined that your esophagus is mildly affected, the recommended dose is one 40 mg esomeprazole gastro-resistant tablet once daily for 4 weeks. Your doctor may instruct you to continue the same dose for another 4 weeks if your esophagus has not yet healed.
  • If you have severe liver problems, your doctor may prescribe a lower dose.

How to take this medicine

  • You may take the tablets at any time of day.
  • You may take the tablets with food or on an empty stomach.
  • Swallow the tablets whole with a glass of water. Do not chew or crush the tablets. This is because the tablets contain coated granules that prevent the medicine from being destroyed by stomach acid. It is important not to damage the granules.

What to do if you have difficulty swallowing

  • If you have difficulty swallowing the tablets:

  • Place the tablets in a glass of still (non-carbonated) water. Do not use any other liquids.

  • Stir until the tablets disintegrate (the solution will not be transparent). You may drink the mixture immediately or within 30 minutes. Always stir again just before drinking.

  • To ensure you have taken the full dose, rinse the glass thoroughly with half a glass of water and drink it. The solid particles contain the medicine – do not chew or crush the granules.

  • If you cannot swallow at all, the tablets may be dispersed in water and administered via a syringe. They can then be delivered directly into the stomach through a feeding tube (gastric tube).

Use in children under 12 years of age

Esomeprazole is not recommended for children under 12 years of age.

Information on dosing for children aged 1 to 11 years is provided in the esomeprazole powder for oral suspension product information (consult your doctor or pharmacist if you need further information).

Elderly patients

Dose adjustment is not necessary in elderly patients.

If you take more Esomeprazol Combix than you should

If you take more esomeprazole than your doctor has prescribed, consult your doctor or pharmacist immediately.

In case of overdose or accidental ingestion, you may also call the Toxicology Information Service at telephone number 91 562 04 20, stating the name of the medicine and the amount taken. It is recommended to bring the medicine packaging and leaflet to the healthcare professional.

If you forget to take Esomeprazol Combix

  • If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next dose, do not take the missed dose.
  • Do not take a double dose to make up for forgotten doses.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.

If you notice any of the following serious adverse effects, stop taking Esomeprazol Combix and contact a doctor immediately:

  • Sudden difficulty breathing, swelling of the lips, tongue and throat or of the body in general, skin rash, fainting or difficulty swallowing (severe allergic reaction).

  • Red skin with blisters or peeling. Severe blisters and bleeding of the lips, eyes, mouth, nose and genitals may also occur. These could be signs of “Stevens-Johnson syndrome” or “toxic epidermal necrolysis”.

  • Yellowing of the skin, dark urine and tiredness, which may be symptoms of liver problems.

  • Widespread rash, high body temperature and enlarged lymph nodes (DRESS syndrome or drug hypersensitivity syndrome), which is very rare.

These effects are rare and may affect up to 1 in 1,000 people.

Other adverse effects include:

Frequent (may affect up to 1 in 10 people)

  • Headache.
  • Stomach or intestinal effects: stomach pain, constipation, diarrhea, gas (flatulence).
  • Nausea or vomiting.
  • Benign polyps in the stomach.

Uncommon (may affect up to 1 in 100 people)

  • Swelling of feet and ankles.
  • Sleep disturbance (insomnia).
  • Dizziness, tingling sensation and numbness, drowsiness.
  • Sensation of vertigo.
  • Dry mouth.
  • Abnormal blood test results indicating liver function.
  • Skin rash, hives, skin itching.
  • Fracture of hip, wrist or spine (if Esomeprazol Combix is used at high doses and for a long period).

Rare (may affect up to 1 in 1,000 people)

  • Blood disorders such as reduced number of white blood cells or platelets. This may cause weakness, bruising or increased risk of infections.
  • Low sodium levels in blood. This may cause weakness, vomiting and cramps.
  • Restlessness, confusion or depression.
  • Taste disturbances.
  • Eye disorders such as blurred vision.
  • Sudden sensation of breathlessness or difficulty breathing (bronchospasm).
  • Inflammation inside the mouth.
  • A fungal infection known as “candidiasis” which may affect the esophagus.
  • Liver problems including jaundice, which may cause yellowing of the skin, dark urine and tiredness.
  • Hair loss (alopecia).
  • Dermatitis due to exposure to sunlight.
  • Joint pain (arthralgia) or muscle pain (myalgia).
  • General feeling of malaise and lack of energy.
  • Increased sweating.

Very rare (may affect up to 1 in 10,000 people)

  • Changes in blood cell counts, including agranulocytosis (reduced number of white blood cells).
  • Aggressiveness.
  • Seeing, feeling or hearing things that are not real (hallucinations).
  • Liver disorders that may lead to liver failure or brain inflammation.
  • Sudden onset of severe skin rash, blisters or skin peeling. These symptoms may be accompanied by high fever and joint pain. (Erythema multiforme, Stevens-Johnson syndrome, Toxic epidermal necrolysis).
  • Muscle weakness.
  • Severe kidney problems.
  • Enlargement of the breasts in men.

Frequency not known (frequency cannot be estimated from available data)

  • If you are being treated with Esomeprazol Combix for more than three months, your blood magnesium levels may decrease. Low magnesium levels may present as fatigue, involuntary muscle contractions, disorientation, seizures, dizziness or increased heart rate. If you experience any of these symptoms, inform your doctor immediately. Low magnesium levels may also lead to reduced levels of potassium or calcium in the blood.

Your doctor may decide to perform periodic blood tests to monitor your magnesium levels.

  • Inflammation of the intestine (may lead to diarrhea).
  • Skin rash, possibly with joint pain.

In very rare cases, esomeprazole may affect white blood cells, causing immune deficiency.

If you develop an infection with symptoms such as fever accompanied by a severe deterioration in general condition, or fever with signs of a local infection such as neck, throat or mouth pain, or difficulty urinating, you should consult your doctor as soon as possible to rule out a reduced number of white blood cells (agranulocytosis) by means of a blood test. In such cases, it is important that you inform your doctor about the medication you are taking.

Reporting of adverse effects

If you experience any adverse effects, consult your doctor or pharmacist, even if they are possible adverse effects not listed in this leaflet. You can also report them directly via the Spanish Pharmacovigilance System for Human Medicines: https://www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Esomeprazol Combix

Keep this medicine out of the sight and reach of children.

Do not store above 25°C.

Keep in the original packaging to protect from moisture.

Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date refers to the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Dispose of unused medicines and their containers at the SIGRE collection point in your pharmacy. Ask your pharmacist how to properly dispose of medicines and containers you no longer need. This way, you will help protect the environment.

6. Package contents and other information

Composition of Esomeprazole Combix

  • The active substance is esomeprazole. Each gastro-resistant tablet contains 40 mg of esomeprazole (as esomeprazole magnesium dihydrate).
  • The other components are:

Tablet core: sugar spheres (sucrose and corn starch), hydroxypropylcellulose (E463), light magnesium oxide (E530).

Coating: povidone K-30, mannitol (E421), magnesium stearate (vegetable) (E470b), methacrylic acid-ethyl acrylate copolymer, polysorbate 80 (E433), triethyl citrate (E1507), glyceryl monostearate 40-55 (E472a), hypromellose, macrogol 8000, silicified microcrystalline cellulose (E460i), microcrystalline cellulose (E460i), crospovidone (type A), copovidone, talc, Opadry pink 20A54019 (composed of hypromellose, hydroxypropylcellulose (E463), titanium dioxide (E171), talc and iron oxide red (E172)).

Appearance of the product and contents of the pack

Pink, oval, biconvex, bevel-edged, film-coated tablets, engraved with "40" on one side and smooth on the other.

Esomeprazole Combix 40 mg is available in blisters with OPA/Al/PE-PE/Al desiccant, in pack sizes of 14, 28 and 56 tablets.

Only some pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder:

Laboratorios Combix, S.L.U.

C/ Badajoz 2, Edificio 2.

28223 Pozuelo de Alarcón (Madrid)

Spain

Manufacturer:

Zydus France

ZAC Les Hautes Patures

Parc d'activités des Peupliers

25 Rue des Peupliers

92000 Nanterre

France

or

Centre Spécialités Pharmaceutiques

ZAC des Suzots

35 Rue de la Chapelle

63450 Saint Amant Tallende

France

or

Netpharmalab Consulting Services

Carretera de Fuencarral 22,

Alcobendas,

28108 Madrid

Spain

or

Flavine Pharma France

3 Voie d’Allemagne

13127 Vitrolles

France

Date of the most recent revision of this leaflet: February 2025

Other sources of information

Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

This information is intended solely for healthcare professionals:

Administration via gastric tube

  1. Place the tablet into a suitable syringe and fill the syringe with approximately 25 ml of water and approximately 5 ml of air. For some tubes, dispersion in 50 ml of water is required to prevent pellet blockage.

  2. Immediately shake the syringe for about 2 minutes to disperse the tablet.

  3. Hold the syringe with the tip facing upwards and check that the tip is not blocked.

  4. Connect the syringe to the tube while maintaining the previous position.

  5. Shake the syringe and position it with the tip facing downwards. Immediately inject 5–10 ml into the tube. After injection, invert the syringe and shake it (the syringe must be kept with the tip facing upwards to prevent blockage).

  6. Re-position the syringe with the tip facing downwards and immediately inject another 5–10 ml into the tube. Repeat this procedure until the syringe is empty.

  7. Fill the syringe with 25 ml of water and 5 ml of air and repeat step 5 if necessary to flush any remaining sediment from the syringe. For some tubes, 50 ml of water may be required.